Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...

A study in the journal Diabetes Technology & Therapeutics (DTT) concludes that inhaled technosphere insulin (TI-Afrezza) ...

Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c ...

A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) concluded that inhaled technosphere insulin ...

In 2015, the FDA finally approved Tresiba (insulin degludec) and Ryzodeg (insulin aspart and insulin degludec) on the basis of an interim analysis from DEVOTE. The primary endpoint of the DEVOTE ...

Study Rundown: Insulin injections are often introduced to supplement glucose-lowering medications when optimal glucose control in type 2 diabetes is no longer achieved. However, many patients avoid ...

Insulin is a hormone that allows glucose in the blood to enter cells, providing them with the energy to function. A lack of adequate insulin plays a key role in the development of diabetes ...

The various makes and models of pump available use different technological solutions for delivering insulin. To obtain marketing approval, manufacturing companies must submit a premarket ...

A study in mice found that aspartame triggered higher insulin levels – potentially contributing to plaque buildup in arteries. Mice fed aspartame showed more fatty deposits and immune cell activity in ...

Feb. 20, 2025 -- The FDA has approved a new fast-acting insulin biosimilar to help manage blood sugar in people with diabetes, including children and adults. The product, called Merilog ...